The semaphorins: Versatile regulators of tumour progression and tumour angiogenesis

Nature Reviews Cancer

Volumn 8, Issue 8, 2008, Pages 632-645

  Neufeld, Gera ^a   Kessler, Ofra ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; NEUROPILIN; SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN 3B; SEMAPHORIN 3D; SEMAPHORIN 3E; SEMAPHORIN 3F;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BREAST TUMOR; DRUG MECHANISM; HEAD AND NECK CANCER; HUMAN; LUNG TUMOR; MELANOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; TUMOR GROWTH;

CELL ADHESION MOLECULES, NEURONAL; HUMANS; NEOPLASMS; NEUROPILINS; SEMAPHORINS; SIGNAL TRANSDUCTION;

EID: 47949102937     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2404     Document Type: Review

References (170)

1. Luo, Y., Raible, D. & Raper, J. A. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75, 217-227 (1993). This is the first description of a semaphorin.
2. Goodman, C. S., Kolodkin, A. L., Luo, Y., Pueschel, A. W. & Raper, J. A. Unified nomenclature for the semaphorins collapsins. Cell 97, 551-552 (1999).
3. Gherardi, E., Love, C. A., Esnouf, R. M. & Jones, E. Y. The sema domain. Curr. Opin. Struct. Biol. 14, 669-678 (2004).
4. Koppel, A. M., Feiner, L., Kobayashi, H. & Raper, J. A. A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members. Neuron 19, 531-537 (1997).
5. Bork, P., Doerks, T., Springer, T. A. & Snel, B. Domains in plexins: links to integrins and transcription factors. Trends Biochem. Sci. 24, 261-263 (1999).
6. Comoglio, P. M., Boccaccio, C. & Trusolino, L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr. Opin. Cell Biol. 15, 565-571 (2003).
7. Koppel, A. M. & Raper, J. A. Collapsin-1 covalently dimerizes, and dimerization is necessary for collapsing activity. J. Biol. Chem. 273, 15708-15713 (1998).
8. Klostermann, A., Lohrum, M., Adams, R. H. & Puschel, A. W. The chemorepulsive activity of the axonal guidance signal semaphorin D requires dimerization. J. Biol. Chem. 273, 7326-7331 (1998).
9. Basile, J. R., Holmbeck, K., Bugge, T. H. & Gutkind, J. S. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J. Biol. Chem. 282, 6899-6905 (2007).
10. Oinuma, I., Ishikawa, Y., Katoh, H. & Negishi, M. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305, 862-865 (2004). The first paper in which it was found that plexins have a functional GAP domain that controls integrin function.
11. Tong, Y. et al. Binding of Rac1, Rnd1 and RhoD to a novel Rho GTPase interaction motif destabilizes dimerization of the plexin-B1 effector domain. J. Biol. Chem. 282, 37215-37224 (2007).
12. Driessens, M. H. et al. Plexin-B semaphorin receptors interact directly with active Rac and regulate the actin cytoskeleton by activating Rho. Curr. Biol. 11, 339-344 (2001).
13. Rohm, B., Rahim, B., Kleiber, B., Hovatta, I. & Puschel, A. W. The semaphorin 3A receptor may directly regulate the activity of small GTPases. FEBS Lett. 486, 68-72 (2000).
14. Vikis, H. G., Li, W. & Guan, K. L. The plexin-B1/Rac interaction inhibits PAK activation and enhances Sema4D ligand binding. Genes Dev. 16, 836-845 (2002).
15. Aurandt, J., Vikis, H. G., Gutkind, J. S., Ahn, N. & Guan, K. L. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc. Natl Acad. Sci. USA 99, 12085-12090 (2002).
16. Perrot, V., Vazquez-Prado, J. & Gutkind, J. S. Plexin B regulates Rho through the guanine nucleotide exchange factors Leukemia-associated RhoGEF (LARG) and PDZ-RhoGEF. J. Biol. Chem. 278, 26111-26119 (2002).
17. Swiercz, J. M., Kuner, R., Behrens, J. & Offermanns, S. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 35, 51-63 (2002).
18. Artigiani, S. et al. Functional regulation of semaphorin receptors by proprotein convertases. J. Biol. Chem. 278, 10094-10101 (2003).
19. Takahashi, T. et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 99, 59-69 (1999). The first description of the role of plexins in neuropilin-mediated signal transduction.
20. Tamagnone, L. et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 71-80 (1999). The first description of the role of plexins in neuropilin-mediated signal transduction.
21. Takagi, S. et al. The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors. Neuron 7, 295-307 (1991).
22. He, Z. & Tessier-Lavigne, M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90, 739-751 (1997).
23. Kolodkin, A. L. et al. Neuropilin is a semaphorin III receptor. Cell 90, 753-762 (1997). References 22 and 23 are the first descriptions of neuropilin 1 as a SEMA3A receptor.
24. Giger, R. J. et al. Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 21, 1079-1092 (1998).
25. Chen, H., Chedotal, A., He, Z., Goodman, C. S. & Tessier-Lavigne, M. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 19, 547-559 (1997).
26. Tomizawa, Y. et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc. Natl Acad. Sci. USA 98, 13954-13959 (2001).
27. Julien, F. et al. Dual functional activity of semaphorin 3B is required for positioning the anterior commissure. Neuron 48, 63-75 (2005).
28. Roth, L. et al. Transmembrane domain interactions control biological functions neuropilin-1. Mol. Biol. Cell 19 646-654 (2008).
29. Gu, C. et al. Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. J. Biol. Chem. 277, 18069-18076 (2002).
30. Vander Kooi, C. W. et al. Structural basis for ligand and heparin binding to neuropilin B domains. Proc. Natl Acad. Sci. USA 104, 6157-6152 (2007).
31. Cai, H. B. & Reed, R. R. Cloning and characterization of neuropilin-1-interacting protein: A PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J. Neurosci. 19, 6519-6527 (1999).
32. Gao, Y., Li, M., Chen, W. & Simons, M. Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J. Cell Physiol. 184, 373-379 (2000).
33. Shintani, Y. et al. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J. 25, 3045-3055 (2006).
34. Gitay-Goren, H. et al. Selective binding of VEGF121 to one of the three VEGF receptors of vascular endothelial cells. J. Biol. Chem. 271, 5519-5523 (1996).
35. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell 92, 735-745 (1998). The first description of neuropilin 1 as a functional VEGF receptor.
36. Gluzman-Poltorak, Z., Cohen, T., Herzog, Y. & Neufeld, G. Neuropilin-2 and Neuropilin-1 are receptors for 165-amino acid long form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145 amino acid form of VEGF. J. Biol. Chem. 275, 18040-18045 (2000).
37. Miao, H. Q. et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility. Functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146, 233-242 (1999).
38. Gluzman-Poltorak, Z., Cohen, T., Shibuya, M. & Neufeld, G. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J. Biol. Chem. 276, 18688-18694 (2001).
39. 165-receptor binding. J. Cell. Biochem. 85, 357-368 (2002).
40. Shraga-Heled, N. et al. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. FASEB J. 21, 915-926 (2007).
41. Favier, B. et al. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108, 1243-1250 (2006).
42. Pan, Q. et al. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J. Biol. Chem. 282, 24049-24056 (2007).
43. Wang, L. et al. Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival. PLoS ONE 2, e1161 (2007).
44. Sulpice, E. et al. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood 111, 2036-2045 (2007). Characterization of neuropilins as receptors for HGF.
45. Herzog, Y., Kalcheim, C., Kahane, N., Reshef, R. & Neufeld, G. Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech. Dev. 109, 115-119 (2001).
46. Yuan, L. et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129, 4797-4806 (2002).
47. Moyon, D., Pardanaud, L., Yuan, L., Breant, C. & Eichmann, A. Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 128, 3359-3370 (2001).
48. Shalaby, F. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66 (1995).
49. Takashima, S. et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl Acad. Sci. USA 99, 3657-3662 (2002). A paper showing that neuropilins are essential for vasculogenesis.
50. Makinen, T. et al. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J. Biol. Chem. 274, 21217-21222 (1999).
51. Migdal, M. et al. Neuropilin-1 is a placenta growth factor-2 receptor. J. Biol. Chem. 273, 22272-22278 (1998).
52. Karkkainen, M. J. et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl Acad. Sci. USA 98, 12677-12682 (2001).
53. Karpanen, T. et al. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20, 1462-1472 (2006).
54. Banerjee, S. et al. Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1. Mol. Carcinog. 45, 871-880 (2006).
55. Armulik, A., Abramsson, A. & Betsholtz, C. Endothelial/pericyte interactions. Circ. Res. 97, 512-523 (2005).
56. West, D. C. et al. Interactions of multiple heparin-binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J. Biol. Chem. 280, 13457-13464 (2005).
57. Hsieh, S. H. et al. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 28 Jan 2008 (doi: 10.1038/sj.onc.1211029).
58. Castellani, V., Chedotal, A., Schachner, M., Faivre-Sarrailh, C. & Rougon, G. Analysis of the L1-deficient mouse phenotype reveals cross-talk between Sema3A and L1 signaling pathways in axonal guidance. Neuron 27, 237-249 (2000). A paper showing that SEMA3A is turned from a repulsive agent into an attractive agent in the presence of the extracellular domain of L1CAM.
59. Castellani, V., De Angelis, E., Kenwrick, S. & Rougon, G. Cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A. EMBO J. 21, 6348-6357 (2002).
60. Wright, A. G. et al. Close homolog of L1 and neuropilin 1 mediate guidance of thalamocortical axons at the ventral telencephalon. J. Neurosci. 27, 13667-13679 (2007).
61. Schlatter, M. C., Buhusi, M., Wright, A. G. & Maness, P. F. CHL1 promotes Sema3A-induced growth cone collapse and neurite elaboration through a motif required for recruitment of ERM proteins to the plasma membrane. J. Neurochem. 104, 731-744 (2008).
62. Fukasawa, M., Matsushita, A. & Korc, M. Neuropilin-1 interacts with integrin β1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol. Ther. 6, (2007).
63. Ellis, L. M. The role of neuropilins in cancer. Mol. Cancer Ther. 5, 1099-1107 (2006).
64. Miao, H. Q., Lee, P., Lin, H., Soker, S. & Klagsbrun, M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 14, 2532-2539 (2000).
65. Parikh, A. A. et al. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am. J. Pathol. 164, 2139-2151 (2004).
66. Gray, M. J. et al. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Cancer Res. 65, 3664-3670 (2005).
67. Kamiya, T. et al. The preserved expression of neuropilin (NRP) 1 contributes to a better prognosis in colon cancer. Oncol. Rep. 15, 369-373 (2006).
68. Gray, M. J. et al. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J. Natl Cancer Inst. 100, 109-120 (2008).
69. Roodink, I. et al. Plexin d1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy? Cancer Res. 65, 8317-8323 (2005).
70. Bachelder, R. E. et al. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res. 63, 5230-5233 (2003).
71. Rieger, J., Wick, W. & Weller, M. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42, 379-389 (2003).
72. Syed, V. et al. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells. Oncogene 24, 8128-8143 (2005).
73. Nguyen, Q. D. et al. Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts. Mol. Cancer Ther. 5, 2070-2077 (2006).
74. Wong, O. G. et al. Plexin-B1 mutations in prostate cancer. Proc. Natl Acad. Sci. USA 48, 19040-19045 (2007).
75. Rody, A. et al. Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin b1. Clin. Cancer Res. 13, 1115-1122 (2007).
76. Kuroki, T. et al. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3b in nonsmall cell lung cancer. Cancer Res. 63, 3352-3355 (2003).
77. Tischoff, I. et al. Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int. J. Cancer 115, 684-689 (2005).
78. Nair, P. N., McArdle, L., Cornell, J., Cohn, S. L. & Stallings, R. L. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene. Cancer Genet. Cytogenet. 174, 100-110 (2007).
79. Marsit, C. J., Wiencke, J. K., Liu, M. & Kelsey, K. T. The race associated allele of semaphorin 3B (SEMA3B) T415I and its role in lung cancer in African-Americans and Latino-Americans. Carcinogenesis 26, 1446-1449 (2005).
80. van der Weyden, L. et al. Null and conditional semaphorin 3B alleles using a flexible puroΔtk loxP/FRT vector. Genesis 41, 171-178 (2005).
81. Castro-Rivera, E., Ran, S., Thorpe, P. & Minna, J. D. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc. Natl Acad. Sci. USA 101, 11432-11437 (2004).
82. Xiang, R. H. et al. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 32, 39-48 (1996).
83. Roche, J. et al. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 12, 1289-1297 (1996).
84. Xiang, R. et al. Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res. 62, 2637-2643 (2002).
85. Nasarre, P. et al. Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Neoplasia 5, 83-92 (2003).
86. Nasarre, P. et al. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Neoplasia 7, 180-189 (2005).
87. Bielenberg, D. R. et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J. Clin. Invest. 114, 1260-1271 (2004).
88. Potiron, V. A. et al. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Cancer Res. 67, 8708-8715 (2007).
89. Kusy, S. et al. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia 7, 457-465 (2005).
90. Osada, R. et al. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. Hum. Pathol. 37, 1414-1425 (2006).
91. Herman, J. G. & Meadows, G. G. Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. Int. J. Oncol. 30, 1231-1238 (2007).
92. Muller, M. W. et al. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int. J. Cancer 121, 2421-2433 (2007).
93. Catalano, A. et al. Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J. 18, 358-360 (2004).
94. Acevedo, L. M., Barillas, S., Weis, S. M., Gothert, J. R. & Cheresh, D. A. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 111, 2674-2680 (2008).
95. Martin-Satue, M. & Blanco, J. Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J. Surg. Oncol. 72, 18-23 (1999).
96. Banu, N., Teichman, J., Dunlap-Brown, M., Villegas, G. & Tufro, A. Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J. 20, 2150-2152 (2006).
97. Giordano, S. et al. The Semaphorin 4D receptor controls invasive growth by coupling with Met. Nature Cell Biol. 4, 720-724 (2002). The first description of plexin-mediated activation of a tyrosine kinase receptor by a semaphorin.
98. Conrotto, P., Corso, S., Gamberini, S., Comoglio, P. M. & Giordano, S. Interplay between scatter factor receptors and B plexins controls invasive growth. Oncogene 23, 5131-5137 (2004).
99. Hu, B. et al. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 26, 5577-5586 (2007).
100. Citri, A. & Yarden, Y. EGF-ERBB signalling: towards the systems level. Nature Rev. Mol. Cell Biol. 7, 505-516 (2006).
101. Swiercz, J. M., Kuner, R. & Offermanns, S. Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J. Cell Biol. 165, 869-880 (2004).
102. Swiercz, J. M., Worzfeld, T. & Offermanns, S. ERBB-2 and met reciprocally regulate cellular signaling via plexin-B1. J. Biol. Chem. 283, 1893-1901 (2008).
103. Artigiani, S. et al. Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep. 5, 710-714 (2004).
104. Hirota, E. et al. Genome-wide gene expression profiles of clear cell renal cell carcinoma: Identification of molecular targets for treatment of renal cell carcinoma. Int. J. Oncol. 29, 799-827 (2006).
105. Nagai, H. et al. CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells. Oncogene 26, 4025-4031 (2007).
106. Serini, G. et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424, 391-397 (2003). First description of semaphorins as modulators of integrin function.
107. Guttmann-Raviv, N. et al. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem. 282, 26294-26305 (2007).
108. Vieira, J. M., Schwarz, Q. & Ruhrberg, C. Selective requirements for NRP1 ligands during neurovascular patterning. Development 134, 1833-1843 (2007).
109. Gu, C. et al. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev. Cell 5, 45-57 (2003).
110. Kessler, O. et al. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res. 64, 1008-1015 (2004). The first description of a semaphorin as an inhibitor of tumour angiogenesis.
111. Futamura, M. et al. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression. Cancer Res. 67, 1451-1460 (2007).
112. Gu, C. et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307, 265-268 (2005). This paper changes a dogma by showing that the class 3 semaphorin SEMA3E signals directly through plexin D1 and repels blood vessels during embryonic development.
113. Gitler, A. D., Lu, M. M. & Epstein, J. A. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev. Cell 7, 107-116 (2004).
114. Chauvet, S. et al. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron 56, 807-822 (2007).
115. Toyofuku, T. et al. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via plexin-D1. EMBO J. 26, 1373-1384 (2007).
116. Dhanabal, M. et al. Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis. Cancer Biol. Ther. 4, 659-668 (2005).
117. Caunt, M. et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13, 331-342 (2008). This manuscript demonstrates that antibodies to neuropilin 2 can inhibit tumour metastasis through inhibition of lymphangiogenesis.
118. Zhu, L. et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc. Natl Acad. Sci. USA 104, 1621-1626 (2007).
119. Basile, J. R., Barac, A., Zhu, T., Guan, K. L. & Gutkind, J. S. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res. 64, 5212-5224 (2004).
120. Basile, J. R., Castilho, R. M., Williams, V. P. & Gutkind, J. S. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc. Natl Acad. Sci. USA 103, 9017-9022 (2006). The first demonstration that a semaphorin can promote tumour progression through induction of angiogenesis.
121. Conrotto, P. et al. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 105, 4321-4329 (2005).
122. Fazzari, P. et al. PlexinB1 plays a redundant role during mouse development and in tumour angiogenesis. BMC Dev. Biol. 7, 55 (2007).
123. Toyofuku, T. et al. Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev. 18, 435-447 (2004).
124. Pan, Q. et al. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11, 53-67 (2007). This paper shows that antibodies directed against neuropilins have a potential use as supressors of tumour development.
125. Matsushita, A., Gotze, T. & Korc, M. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res. 67, 10309-10316 (2007).
126. Deaglio, S. et al. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 105, 3042-3050 (2005).
127. + B lymphocytes. Blood 101, 1962-1969 (2003).
128. Bassi, D. E., Fu, J., Lopez de, C. R. & Klein-Szanto, A. J. Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol. Carcinog. 44, 151-161 (2005).
129. Adams, R. H., Lohrum, M., Klostermann, A., Betz, H. & Puschel, A. W. The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing. EMBO J. 16, 6077-6086 (1997).
130. Christensen, C. et al. Proteolytic processing converts the repelling signal sema3e into an inducer of invasive growth and lung metastasis. Cancer Res. 65, 6167-6177 (2005).
131. Chen, G. et al. Semaphorin-3A guides radial migration of cortical neurons during development. Nature Neurosci. 11, 36-44 (2008).
132. Yaron, A., Huang, P. H., Cheng, H. J. & Tessier-Lavigne, M. Differential requirement for plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 semaphorins. Neuron 45, 513-523 (2005).
133. Takahashi, T. & Strittmatter, S. M. PlexinA1 autoinhibition by the plexin sema domain. Neuron 29, 429-439 (2001). This manuscript demonstrates a role for the sema domain of plexin in the inhibition of plexin activity in the absence of semaphorins.
134. Toyofuku, T. et al. FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nature Neurosci. 8, 1712-1719 (2005). Description of the role of FARP2 in SEMA3A-induced activation of the PLEXA1 GAP activity.
135. Komatsu, M. & Ruoslahti, E. R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis. Nature Med. 11, 1346-1350 (2005).
136. Zanata, S. M., Hovatta, I., Rohm, B. & Puschel, A. W. Antagonistic effects of Rnd1 and RhoD GTPases regulate receptor activity in Semaphorin 3A-induced cytoskeletal collapse. J. Neurosci. 22, 471-477 (2002).
137. Tadokoro, S. et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 302, 103-106 (2003).
138. Aizawa, H. et al. Phosphorylation of cofilin by LIM-kinase is necessary for semaphorin 3A- induced growth cone collapse. Nature Neurosci. 4, 367-373 (2001).
139. Bernard, O. Lim kinases, regulators of actin dynamics. Int. J. Biochem. Cell Biol. 39, 1071-1076 (2007).
140. Mitsui, N. et al. Involvement of Fes/Fps tyrosine kinase in semaphorin3A signaling. EMBO J. 21, 3274-3285 (2002).
141. Shapovalova, Z., Tabunshchyk, K. & Greer, P. A. The Fer tyrosine kinase regulates an axon retraction response to Semaphorin 3A in dorsal root ganglion neurons. BMC Dev. Biol. 7, 133 (2007).
142. Sasaki, Y. et al. Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 35, 907-920 (2002).
143. Uchida, Y. et al. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 10, 165-179 (2005).
144. Arimura, N. et al. Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol. Cell Biol. 25, 9973-9984 (2005).
145. Hall, C. et al. Collapsin response mediator protein switches RhoA and Rac1 morphology in N1E-115 neuroblastoma cells and is regulated by Rho kinase. J. Biol. Chem. 276, 43482-43486 (2001).
146. Terman, J. R., Mao, T., Pasterkamp, R. J., Yu, H. H. & Kolodkin, A. L. MICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsion. Cell 109, 887-900 (2002).
147. Pasterkamp, R. J. et al. MICAL flavoprotein monooxygenases: Expression during neural development and following spinal cord injuries in the rat. Mol. Cell Neurosci. 31, 52-69 (2006).
148. Schmidt, E. F., Shim, S. O. & Strittmatter, S. M. Release of MICAL autoinhibition by semaphorin-plexin signaling promotes interaction with collapsin response mediator protein. J. Neurosci. 28, 2287-2297 (2008).
149. Togashi, H., Schmidt, E. F. & Strittmatter, S. M. RanBPM contributes to Semaphorin3A signaling through plexin-A receptors. J. Neurosci. 26, 4961-4969 (2006).
150. Fan, J., Mansfield, S. G., Redmond, T., Gordon-Weeks, P. R. & Raper, J. A. The organization of F-actin and microtubules in growth cones exposed to a brain-derived collapsing factor. J. Cell Biol. 121, 867-878 (1993).
151. Shirvan, A. et al. Semaphorins as mediators of neuronal apoptosis. J. Neurochem. 73, 961-971 (1999). The first description of a semaphorin as an inducer of apoptosis.
152. Bagnard, D. et al. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J. Neurosci. 21, 3332-3341 (2001).
153. Basile, J. R., Gavard, J. & Gutkind, J. S. Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. J. Biol. Chem. 282, 34888-34895 (2007).
154. Barberis, D. et al. p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling. J Cell Sci. 118, 4689-4700 (2005).
155. Ito, Y., Oinuma, I., Katoh, H., Kaibuchi, K. & Negishi, M. Sema4D/plexin-B1 activates GSK-3β through R-Ras GAP activity, inducing growth cone collapse. EMBO Rep. 7, 704-709 (2006).
156. Fukata, Y. et al. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nature Cell Biol. 4, 583-591 (2002).
157. Potiron, V., Nasarre, P., Roche, J., Healy, C. & Boumsell, L. Semaphorin signaling in the immune system. Adv. Exp. Med. Biol. 600, 132-144 (2007).
158. Kikutani, H., Suzuki, K. & Kumanogoh, A. Immune semaphorins: increasing members and their diverse roles. Adv. Immunol. 93, 121-143 (2007).
159. Catalano, A. et al. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 107, 3321-3329 (2006).
160. Yazdani, U. & Terman, J. R. The semaphorins. Genome Biol. 7, 211 (2006).
161. Kumanogoh, A. et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419, 629-633 (2002).
162. Kumanogoh, A. et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 13, 621-631 (2000).
163. Kantor, D. B. et al. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 44, 961-975 (2004).
164. Klagsbrun, M. & Eichmann, A. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev. 16, 535-548 (2005).
165. Kuijper, S., Turner, C. J. & Adams, R. H. Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc. Med. 17, 145-151 (2007).
166. Wilson, N. H. & Key, B. Neogenin: one receptor, many functions. Int. J. Biochem. Cell Biol. 39, 874-878 (2007).
167. Autiero, M., De Smet, F., Claes, F. & Carmeliet, P. Role of neural guidance signals in blood vessel navigation. Cardiovasc. Res. 65, 629-638 (2005).
168. Mehlen, P. & Llambi, F. Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers. Br. J. Cancer. 93, 1-6 (2005).
169. Fujiwara, M., Ghazizadeh, M. & Kawanami, O. Potential role of the Slit/Robo signal pathway in angiogenesis. Vasc. Med. 11, 115-121 (2006).
170. Glinka, Y. & Prud'homme, G. J. Neuropilin-1 is a receptor for transforming growth factorβ-1, activates its latent form, and promotes regulatory T cell activity. J. Leukoc. Biol. (in the press).